Biotech · Private company · Alpharetta, GA, US
Alimera Sciences Inc
SEC CIK 0001267602
Track this companyFree. Adds Alimera Sciences Inc to your Dealase workspace and tells you when its record changes.
Clinical trials52 recruiting or active
Pipeline programs4From trials and the company's site
Disclosed deals0None found yet
Cash runwayNot availablePrivate: no SEC financials
Pipeline4
- AfliberceptDiabetic Macular EdemaClinicalTrials.gov · fetched Nov 12, 2026
- Fluocinolone Acetonide Intravitreal Implant 0.18 mgUveitis, PosteriorClinicalTrials.gov · fetched Nov 12, 2026
- ILUVIEN 0.19 MGDiabetic Macular Edema (DME)ClinicalTrials.gov · fetched Nov 12, 2026
- Iluvien 0.19 MG Drug ImplantDiabetic Macular EdemaClinicalTrials.gov · fetched Nov 12, 2026
Clinical trials5
- Intravitreal Faricimab Injections or Fluocinolone Acetonide (0.19 mg) Intravitreal Implants vs Observation for Prevention of VA Loss Due to Radiation RetinopathyPHASE3 · RECRUITING · started Nov 21, 2023ClinicalTrials.gov NCT05844982 · fetched Nov 12, 2026
- Fluocinolone Acetonide Intravitreal Implant 0.18 mg in the Treatment of Chronic Non-Infectious Posterior Segment UveitisPHASE4 · UNKNOWN · started Jun 6, 2022ClinicalTrials.gov NCT05322070 · fetched Nov 12, 2026
- A Study of Intravitreal ILUVIEN® Implant as Baseline Therapy in Patients With Early Diabetic Macular Edema (DME)PHASE4 · ACTIVE_NOT_RECRUITING · started Aug 31, 2020ClinicalTrials.gov NCT04469595 · fetched Nov 12, 2026
- Phase 4 IOP Signals Associated With ILUVIEN®PHASE4 · COMPLETED · started May 6, 2015ClinicalTrials.gov NCT02424019 · fetched Nov 12, 2026
- Iluvien Registry Safety StudyUNKNOWN · started Dec 1, 2013ClinicalTrials.gov NCT01998412 · fetched Nov 12, 2026